This study revealed that, after adjusting for tumor metastatic lymphoid node numbers, the patients who received auto-TIL–based ACT treatment had a longer relapse-free survival (RFS) and OS compared with the patients who received the IL-2 injection only (16, 28, 29). Here, IL2 is linked to neoplasm.